Overview (18 Sep 2026)
Kimia Biosciences Ltd
KIMIABL
INE285U01025

Pharmaceuticals
1.28

Prev. Close
Previous Close
28.11
Current Close
29.39
Current High
30
Current Low
27.97
52 Week High
43.28
52 Week Low
23.2
Resistance 1
30.27
Resistance 2
31.15
Support 1
28.24
Support 2
26.21
Std Deviation
5.89%
DMA 200
31.90
DMA 50
29.97
DMA 20
28.63
Fundamentals and Ratios
Standalone
Trailing EPS
1.64
Forwad EPS
1.84
Trailing P/E
17.92
Forward P/E
15.97
PEG Ratio
3.49
Mkt. Cap (Cr)
Market Cap (Cr)
139.05
Total Debt(Cr)
Tot. Debt(Cr)
32.57
Reserve (Cr)
5.23
Book Value
2.21
P/BV Ratio
13.3
ROCE(%)
26.00
ROE
109.00

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue20.7227.230.13423.58114.88
Other Income0.081.010.10-0.330.851.62
Total Income20.8028.2130.2033.6724.43116.51
Interest0.830.750.750.271.753.52
Expenditure-20.31-26.44-25.15-32.72-23.70-108.05
PBDT0.000.000.000.000.000.00
Depreciation-1.11-1.16-0.85-0.97-0.94-3.91
PBT0.491.765.050.950.698.46
Tax-0.13-1.390.390.070.00-1.03
Equity0.000.000.000.000.000.00
OPM2.366.4916.792.792.937.00
Net Profit0.360.375.441.020.67.43
NPM1.721.3718.082.992.566
EPS0.080.151.150.2101.64
Consolidated
TypeFY24-25
Revenue118.921
Other Income1.32
Total Income120.24
Interest4.56
Expenditure-106.61
PBDT0.00
Depreciation-3.38
PBT13.63
Tax-4.02
Equity4.73
OPM11.34
Net Profit9.61
NPM7.99
EPS2.03
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings